drugset / Trial / NCT00002595

Toremifene in Treating Patients With Desmoid Tumors

NCT00002595

Phase 2 Completed 72 enrolled Advocate Lutheran General Hospital
Treatment

Summary

RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using toremifene may fight the growth of desmoid tumors by reducing the production of estrogen. PURPOSE: Phase II trial to study the effectiveness of toremifene in treating patients with desmoid tumors.

Timeline

Start
1991-07
Primary completion
2003-05
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Toremifene Small molecule Oral

Indications